H.R. 6130

Summary

The Alzheimer's Screening and Prevention Act provides Medicare coverage for blood-based dementia screening tests starting January 1, 2028. The bill covers FDA-cleared or approved tests including genomic sequencing, protein expression, and other blood or tissue tests that can detect pre-symptomatic and early-stage Alzheimer's disease and related dementias.

Latest Action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.